| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| PCAT1 |
|
prostate cancer associated transcript 1
|
|
|
0.575 |
0.615 |
| MIR3681HG |
|
MIR3681 host gene
|
|
|
0.736 |
0.269 |
| LINC01185 |
|
long intergenic non-protein coding RNA 1185
|
|
|
0.743 |
0.346 |
| IL12A-AS1 |
|
IL12A antisense RNA 1
|
|
|
0.633 |
0.654 |
| CASC19 |
|
cancer susceptibility 19
|
|
|
0.769 |
0.423 |
| LINC01147 |
|
long intergenic non-protein coding RNA 1147
|
|
|
0.821 |
0.192 |
| MIR181A1HG |
|
MIR181A1 host gene
|
|
|
0.861 |
0.115 |
| WTAPP1 |
|
Wilms tumor 1 associated protein pseudogene 1
|
|
|
0.890 |
0.154 |
| LINC02580 |
|
long intergenic non-protein coding RNA 2580
|
|
|
0.931 |
0.192 |
| CHROMR |
|
cholesterol induced regulator of metabolism RNA
|
|
|
0.861 |
0.154 |
| LINC01967 |
|
long intergenic non-protein coding RNA 1967
|
|
|
0.931 |
0.115 |
| LINC01100 |
|
long intergenic non-protein coding RNA 1100
|
|
7.3E-02 |
0.861 |
0.192 |
| HLA-F-AS1 |
|
HLA-F antisense RNA 1
|
|
|
0.861 |
0.269 |
| HLA-DRB6 |
|
major histocompatibility complex, class II, DR beta 6 (pseudogene)
|
|
|
0.821 |
0.308 |
| HNRNPA1P68 |
|
heterogeneous nuclear ribonucleoprotein A1 pseudogene 68
|
|
|
1.000 |
0.077 |
| PKIA-AS1 |
|
PKIA antisense RNA 1
|
|
|
1.000 |
0.077 |
| ZNF433-AS1 |
|
ZNF433 and ZNF878 antisense RNA 1
|
|
|
1.000 |
0.077 |
| TTC34 |
A8MYJ7
|
tetratricopeptide repeat domain 34
|
|
6.5E-11 |
0.890 |
0.192 |
| MANBA |
O00462
|
mannosidase beta
|
Enzyme
|
1.3E-18 |
0.736 |
0.462 |
| TNPO2 |
O14787
|
transportin 2
|
Transporter
|
1.00 |
0.861 |
0.231 |
| ARHGEF10 |
O15013
|
Rho guanine nucleotide exchange factor 10
|
Enzyme
|
6.8E-30 |
0.729 |
0.577 |
| CYP27B1 |
O15528
|
cytochrome P450 family 27 subfamily B member 1
|
Enzyme
|
1.9E-07 |
0.502 |
0.769 |
| PHGDH |
O43175
|
phosphoglycerate dehydrogenase
|
Enzyme
|
1.3E-04 |
0.484 |
0.885 |